Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Purchases 100,000 Shares

Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers purchased 100,000 shares of the company’s stock in a transaction dated Wednesday, August 28th. The stock was purchased at an average price of $0.13 per share, for a total transaction of $13,000.00. Following the completion of the purchase, the director now owns 2,325,000 shares in the company, valued at $302,250. The transaction was disclosed in a filing with the SEC, which is available at this link.

Zomedica Stock Up 1.0 %

NYSEAMERICAN:ZOM traded up $0.00 on Thursday, reaching $0.13. 538,552 shares of the company’s stock traded hands, compared to its average volume of 4,859,673. The stock has a market cap of $124.85 million, a PE ratio of -3.15 and a beta of 0.97. Zomedica Corp. has a 12 month low of $0.12 and a 12 month high of $0.23.

Institutional Investors Weigh In On Zomedica

A number of institutional investors and hedge funds have recently modified their holdings of the business. Virtu Financial LLC lifted its stake in shares of Zomedica by 1,585.0% during the first quarter. Virtu Financial LLC now owns 168,773 shares of the company’s stock worth $25,000 after buying an additional 158,757 shares during the period. Frazier Financial Advisors LLC purchased a new position in shares of Zomedica in the fourth quarter valued at approximately $50,000. Finally, Price T Rowe Associates Inc. MD boosted its position in Zomedica by 41.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 948,300 shares of the company’s stock worth $139,000 after acquiring an additional 276,100 shares during the last quarter. 8.95% of the stock is owned by institutional investors.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.